EISAI CO LTD SPONS A Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
E Statistics Lesson
Article By: Vivian Lewis
Sunday, July 29, 2018 10:20 AM EST
I did graduate work on statistics and therefore know exactly what went wrong with some of the FAANG stocks. Blame The Law Of Large Numbers which applies to Netflix, Facebook, and now Twitter and Intel.
In this article: BP, NOK, NVS, VOD, ESALY, NPSNY, OROCF, TEVA, MNILY, AVLIF, AGC, EXG, JOF, PDI
Read
Why Biotech Stocks Rallied On Biogen's Alzheimer's Test
Article By: Zacks Investment Research
Sunday, July 8, 2018 5:48 PM EST
Several major biotech stocks rallied on Friday after Biogen BIIB reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive decline and Alzheimer’s disease.
In this article: ESALY, IBB, AMGN, BIIB, CELG, GILD
Read
Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected
Article By: Zacks Investment Research
Tuesday, May 12, 2015 6:27 AM EST
Arena Pharmaceuticals, Inc. (ARNA) reported a first-quarter 2015 loss of 10 cents per share, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 12 cents.
In this article: ARNA, ESALY Also: GILD, ALIOF
Read
Week In Review: Eddingpharm Pays $169 Million For China Rights To Omega-3 Drug
Article By: ChinaBio® Today
Sunday, March 1, 2015 5:52 PM EST
Eddingpharm, a China in-licensing company, signed a deal worth up to $169 million for China rights to Vascepa®, a prescription omega-3 drug from Amarin Corp and more Pharma/Biotech news.
In this article: AMRN, ESALF, ESALY, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $ESALY

No tweets yet!